2026 Global: Breast Tissue Markers Market -Competitive Review (2032) report
Description
The 2026 Global: Breast Tissue Markers Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for breast tissue markers market by geography and historical trend. The scope of the report extends to sizing of the breast tissue markers market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Hologic, Inc., a leader in women’s health technologies, dominates the breast tissue markers market with a broad portfolio that includes biopsy systems and marker clips, leveraging acquisitions such as SOMATEX to expand marker and localization offerings and strong global distribution to support clinician adoption. Becton, Dickinson and Company (BD) supplies widely used biopsy marker devices and vacuum-assisted biopsy systems, combining imaging-compatible markers with integrated biopsy solutions to serve hospitals and outpatient centers worldwide. Devicor Medical Products (Mammotome), part of Danaher/Leica Biosystems, is recognized for its Mammotome vacuum-assisted biopsy platforms and associated marker technologies, positioning the company as a key supplier for minimally invasive tissue sampling and post‑biopsy site marking. Argon Medical Devices provides a range of biopsy accessories and markers and has expanded its reach through targeted acquisitions and distributor partnerships, enabling scale in European and North American markets for cost‑effective marker products. Mermaid Medical and Carbon Medical Technology are specialty manufacturers focused on marker design and biocompatible materials—such as titanium markers—addressing demand for visibility under multimodal imaging and competitive price points favored by outpatient centers and ASCs. INRAD and Cortex produce niche marker lines and localization tools that emphasize MRI‑ and ultrasound‑compatible designs, supporting clinicians who require consistent marker visualization across imaging modalities and contributing to the mid‑market segment of the industry. Cook Medical and Merit Medical Systems offer complementary portfolios of biopsy devices and marker clips, integrating marker solutions with their procedural systems to simplify workflow for interventional radiology and breast centers and to increase adoption through bundled offerings. Thermo Fisher Scientific, while primarily known for laboratory instrumentation, is identified in market analyses as a contributor to the broader breast tissue marker ecosystem through distribution channels and specialty consumables that support pathology and localization workflows in large hospital networks. Endomag and Scion Medical Technologies represent innovators in localization and marker technologies, with Endomag’s magnetic localization and Scion’s marker designs addressing clinician needs for precise surgical localization and excision planning, thereby strengthening their positions in niche and growing segments of the market.
These ten companies together span the full value chain from biopsy acquisition systems to permanent marker implants and localization devices, driving product differentiation through materials science (for example, titanium markers), multimodal imaging compatibility, and integrated procedural workflows that reduce recall and re‑excision rates. Market reports show concentration among leading suppliers—Hologic, Mammotome/Devicor, and BD account for a substantial share—while specialized players such as Endomag, Carbon Medical, and Scion capture growth in innovation and niche applications. Strategic moves—acquisitions, regional distribution partnerships, and iterative product launches enhancing marker visibility and biocompatibility—are the primary competitive levers these companies use to expand market presence across hospitals, specialty clinics, and ambulatory surgical centers where breast biopsy and marker placement volumes continue to grow.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for breast tissue markers market by geography and historical trend. The scope of the report extends to sizing of the breast tissue markers market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Hologic, Inc., a leader in women’s health technologies, dominates the breast tissue markers market with a broad portfolio that includes biopsy systems and marker clips, leveraging acquisitions such as SOMATEX to expand marker and localization offerings and strong global distribution to support clinician adoption. Becton, Dickinson and Company (BD) supplies widely used biopsy marker devices and vacuum-assisted biopsy systems, combining imaging-compatible markers with integrated biopsy solutions to serve hospitals and outpatient centers worldwide. Devicor Medical Products (Mammotome), part of Danaher/Leica Biosystems, is recognized for its Mammotome vacuum-assisted biopsy platforms and associated marker technologies, positioning the company as a key supplier for minimally invasive tissue sampling and post‑biopsy site marking. Argon Medical Devices provides a range of biopsy accessories and markers and has expanded its reach through targeted acquisitions and distributor partnerships, enabling scale in European and North American markets for cost‑effective marker products. Mermaid Medical and Carbon Medical Technology are specialty manufacturers focused on marker design and biocompatible materials—such as titanium markers—addressing demand for visibility under multimodal imaging and competitive price points favored by outpatient centers and ASCs. INRAD and Cortex produce niche marker lines and localization tools that emphasize MRI‑ and ultrasound‑compatible designs, supporting clinicians who require consistent marker visualization across imaging modalities and contributing to the mid‑market segment of the industry. Cook Medical and Merit Medical Systems offer complementary portfolios of biopsy devices and marker clips, integrating marker solutions with their procedural systems to simplify workflow for interventional radiology and breast centers and to increase adoption through bundled offerings. Thermo Fisher Scientific, while primarily known for laboratory instrumentation, is identified in market analyses as a contributor to the broader breast tissue marker ecosystem through distribution channels and specialty consumables that support pathology and localization workflows in large hospital networks. Endomag and Scion Medical Technologies represent innovators in localization and marker technologies, with Endomag’s magnetic localization and Scion’s marker designs addressing clinician needs for precise surgical localization and excision planning, thereby strengthening their positions in niche and growing segments of the market.
These ten companies together span the full value chain from biopsy acquisition systems to permanent marker implants and localization devices, driving product differentiation through materials science (for example, titanium markers), multimodal imaging compatibility, and integrated procedural workflows that reduce recall and re‑excision rates. Market reports show concentration among leading suppliers—Hologic, Mammotome/Devicor, and BD account for a substantial share—while specialized players such as Endomag, Carbon Medical, and Scion capture growth in innovation and niche applications. Strategic moves—acquisitions, regional distribution partnerships, and iterative product launches enhancing marker visibility and biocompatibility—are the primary competitive levers these companies use to expand market presence across hospitals, specialty clinics, and ambulatory surgical centers where breast biopsy and marker placement volumes continue to grow.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.